Rare eye-risk claims put GLP-1 drugs under sharper scrutiny
A wave of lawsuits in the US alleging vision loss linked to popular weight-loss and diabetes drugs has brought a rare eye condition into focus, raising questions about the long-term safety of medicines that have rapidly gained popularity worldwide.





